Navigation Links
Antares Management Solutions Selects Hyland Software's OnBase
Date:3/11/2008

ocurement, installation and on-going support of OnBase was executed and continues to be maintained by Antares.

About Antares Management Solutions

Antares Management Solutions is a market leader in providing Business Process Outsourcing (BPO) and Information Technology Outsourcing (ITO) services to insurance and other industries. The company's state-of-the-art solutions allow clients to reduce costs and risk while concentrating on their core businesses. Headquartered in Westlake, Ohio, the company manages all aspects of insurance administration and offers integration, delivery and maintenance of information technology, all of which can be customized solutions. For more information, visit http://www.AntaresSolutions.com .

About Hyland Software

Hyland Software Inc. is the developer of OnBase, a rapidly deployable suite of enterprise content management (ECM) software applications. For more information about OnBase, please contact an OnBase Authorized Solution Provider or visit http://www.onbase.com .


'/>"/>
SOURCE Hyland Software
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Antares Management Solutions Attains Gold Certified Partner Status in Microsoft Partner Program
2. Antares Management Solutions Earns Top ISO Re-Certification
3. Antares Management Solutions 2008 NEO Success Award Winner
4. Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry
5. We Care Health Services Inc. partners with IgeaCare Systems Inc. to deliver Healthanywhere(TM) for Chronic Disease Management in Canada.
6. Raintree Systems Launches the First Integrated Practice Management and Electronic Medical Records Application Within the Bariatric Surgery Industry
7. Stabilix Publishes Version 2 of Health Companion, a Personal Healthcare Management Tool
8. Quintiles Data Management Surpasses 300 EDC Trials
9. China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies
10. Standard Management Seeks Additional Shares
11. In Face of Hostile Bargaining and Intimidation by Management, Mills-Peninsula to Vote to Authorize Strike
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Coast Dental Deploys Demandforce D3 Communications Platform 56970 1Coast Dental Deploys Demandforce D3 Communications Platform 56970 2Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 1Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 2Swine Flu Trials Continue to Point to 1 Dose Vaccine 56966 3Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 1Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 4976 2